Ethylene Oxide Attorney in Waukegan, Illinois

The Lake County EtO Cluster

While the Willowbrook Sterigenics litigation in Cook and DuPage counties dominated early Illinois EtO litigation, Lake County has emerged as a second major EtO contamination zone. Medline Industries — one of the nation's largest medical supply manufacturers — operates EtO sterilization facilities in the Waukegan area, and STERIS Corporation operates additional sterilization capacity nearby. Together with the Vantage Specialty Chemicals facility in Gurnee, these operations have created a Lake County EtO cluster that the Illinois EPA has identified as a significant public health concern.

The $48.15 million settlement reached in the Lake County cases validated the community's claims that elevated cancer rates in the area were linked to EtO emissions from these facilities. Unlike the Willowbrook litigation — which focused on a single Sterigenics facility — the Lake County cases involve multiple defendants, complicating apportionment of liability but also expanding the pool of available corporate assets for compensation.

Medline's Role as a Medical Supply Giant

Medline Industries is a privately held company with estimated annual revenues exceeding $20 billion, making it one of the largest private companies in America. Its role as a defendant in EtO litigation is significant because Medline's vertically integrated business model — manufacturing medical supplies and sterilizing them in-house — means the company cannot credibly shift blame to a third-party sterilization contractor. Medline made the business decision to locate EtO sterilization operations in a populated Lake County community, and plaintiffs' attorneys have argued that Medline's resources gave it the ability to invest in emission controls but chose not to.

The settlement structure in the Lake County cases may serve as a model for future EtO settlements involving multi-defendant facilities, particularly in communities where multiple operators contribute to cumulative EtO exposure.